Immunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Upper Extremity Lymphedema
Interventions: DRUG: QBX258
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Novartis